These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23442371)

  • 1. Serum C1q- binding adiponectin in maintenance hemodialysis patients.
    Kishida K; Kishida N; Arima M; Nakatsuji H; Kobayashi H; Funahashi T; Shimomura I
    BMC Nephrol; 2013 Feb; 14():50. PubMed ID: 23442371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between serum C1q-adiponectin/total adiponectin ratio and polyvascular lesions detected by vascular ultrasonography in Japanese type 2 diabetics.
    Hirata A; Kishida K; Kobayashi H; Nakatsuji H; Funahashi T; Shimomura I
    Metabolism; 2013 Mar; 62(3):376-85. PubMed ID: 23058931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum C1q-adiponectin/total adiponectin ratio correlates with coronary artery disease in Japanese type 2 diabetics.
    Hirata A; Kishida K; Nakatsuji H; Kobayashi H; Funahashi T; Shimomura I
    Metabolism; 2013 Apr; 62(4):578-85. PubMed ID: 23174407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amount of C1q-adiponectin complex is higher in the serum and the complex localizes to perivascular areas of fat tissues and the intimal-medial layer of blood vessels of coronary artery disease patients.
    Hong ES; Lim C; Choi HY; Ku EJ; Kim KM; Moon JH; Lim S; Park KS; Jang HC; Choi SH
    Cardiovasc Diabetol; 2015 May; 14():50. PubMed ID: 25956582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q-adiponectin / total adiponectin ratio.
    Nakatsuji H; Kobayashi H; Kishida K; Nakagawa T; Takahashi S; Tanaka H; Akamatsu S; Funahashi T; Shimomura I
    Metabolism; 2013 Jan; 62(1):109-20. PubMed ID: 22819529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum C1q-binding adiponectin levels in male patients with acute coronary syndrome.
    Kishida K; Nakagawa Y; Kobayashi H; Mazaki T; Yokoi H; Yanagi K; Funahashi T; Shimomura I
    Cardiovasc Diabetol; 2014 Jan; 13():9. PubMed ID: 24400991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of circulating C1q and C1q-binding adiponectin concentrations with aging in males: a preliminary report.
    Nakatsuji H; Kishida K; Kobayashi H; Nakagawa T; Funahashi T; Shimomura I
    Diabetol Metab Syndr; 2013 Mar; 5(1):17. PubMed ID: 23531423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum C1q-binding adiponectin complex to total-adiponectin ratio in men with multi-vessel coronary disease.
    Kishida K; Nakagawa Y; Kobayashi H; Yanagi K; Funahashi T; Shimomura I
    Diabetol Metab Syndr; 2014; 6():64. PubMed ID: 24883115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary intervention.
    Kiyokuni M; Konishi M; Saigusa Y; Iwata K; Nakayama N; Komura N; Sugano T; Ishigami T; Ishikawa T; Yamanaka T; Tamura K; Kimura K
    Heart Vessels; 2020 Nov; 35(11):1510-1517. PubMed ID: 32533314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients.
    Ozkok A; Kekik C; Karahan GE; Sakaci T; Ozel A; Unsal A; Yildiz A
    BMC Nephrol; 2013 Nov; 14():241. PubMed ID: 24180481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-month treatment with pioglitazone reduces circulating C1q-binding adiponectin complex to total-adiponectin ratio, without changes in body mass index, in people with type 2 diabetes.
    Nakatsuji H; Kishida K; Kobayashi H; Funahashi T; Shimomura I;
    Diabetes Res Clin Pract; 2013 Jan; 99(1):e14-7. PubMed ID: 23142017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-Specific Associations between Circulating T-Cadherin and High Molecular Weight-Adiponectin in Patients with Stable Coronary Artery Disease.
    Schoenenberger AW; Pfaff D; Dasen B; Frismantiene A; Erne P; Resink TJ; Philippova M
    PLoS One; 2015; 10(6):e0131140. PubMed ID: 26083608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skew of plasma low- and high-density lipoprotein distributions to less dense subfractions in normotriglyceridemic chronic kidney disease patients on maintenance hemodialysis treatment.
    Homma K; Homma Y; Shiina Y; Wakino S; Suzuki M; Fujishima S; Hayashi K; Hori S; Itoh H
    Nephron Clin Pract; 2013; 123(1-2):41-5. PubMed ID: 23752220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C-Adiponectin Complex in Plasma Associates with Coronary Plaque Instability.
    Matsumoto A; Yamamoto H; Matsuoka T; Kayama K; Onishi S; Matsuo N; Kihara S
    J Atheroscler Thromb; 2017 Sep; 24(9):970-979. PubMed ID: 28321013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative Correlation of Serum Adiponectin Levels With Carotid-Femoral Pulse Wave Velocity in Patients Treated With Hemodialysis.
    Hou JS; Wang CH; Lai YH; Lin YL; Kuo CH; Subeq YM; Hsu BG
    Biol Res Nurs; 2018 Jul; 20(4):462-468. PubMed ID: 29635921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birthweight and risk factors for cardiovascular diseases in Japanese schoolchildren.
    Kaneshi T; Yoshida T; Ohshiro T; Nagasaki H; Asato Y; Ohta T
    Pediatr Int; 2007 Apr; 49(2):138-43. PubMed ID: 17445028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of adiponectin and extent of coronary artery disease in patients undergoing elective coronary angiography.
    Souza RA; Alves CMR; de Oliveira CSV; Reis AF; Carvalho AC
    Braz J Med Biol Res; 2017 Nov; 51(2):e6738. PubMed ID: 29211251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the ENRADAS trial.
    Hartl A; Sieper J; Syrbe U; Listing J; Hermann KG; Rudwaleit M; Poddubnyy D
    Arthritis Res Ther; 2017 Jun; 19(1):140. PubMed ID: 28619118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene.
    Ribeiro S; Faria Mdo S; Silva G; Nascimento H; Rocha-Pereira P; Miranda V; Vieira E; Santos R; Mendonça D; Quintanilha A; Costa E; Belo L; Santos-Silva A
    Hemodial Int; 2012 Oct; 16(4):481-90. PubMed ID: 22515595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum adiponectin levels in renal transplant recipients with and without metabolic syndrome.
    Shu KH; Tsai IC; Ho HC; Wu MJ; Chen CH; Cheng CH; Yu TM; Chuang YW; Huang ST
    Transplant Proc; 2012 Apr; 44(3):676-9. PubMed ID: 22483466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.